<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1560</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2022-18-4-81-92</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. TESTICULAR CANCER</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак яичка</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Enhanced recovery program in surgical treatment of patients with germ cell tumors of the testicle: experience of a specialized hospital</article-title><trans-title-group xml:lang="ru"><trans-title>Программа раннего восстановления при хирургическом лечении больных герминогенными опухолями яичка: опыт специализированного стационара</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6883-777X</contrib-id><name-alternatives><name xml:lang="en"><surname>Mamizhev</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Мамижев</surname><given-names>Э. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><bold>Эльдар Мухамедович Мамижев </bold></p><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><email>mamijev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6276-1716</contrib-id><name-alternatives><name xml:lang="en"><surname>Berkut</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Беркут</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8067-9150</contrib-id><name-alternatives><name xml:lang="en"><surname>Rumyantseva</surname><given-names>D. I.</given-names></name><name xml:lang="ru"><surname>Румянцева</surname><given-names>Д. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9625-3907</contrib-id><name-alternatives><name xml:lang="en"><surname>Shchekuteev</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Щекутеев</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Krotov</surname><given-names>N. F.</given-names></name><name xml:lang="ru"><surname>Кротов</surname><given-names>Н. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sigaev</surname><given-names>A. M.</given-names></name><name xml:lang="ru"><surname>Сигаев</surname><given-names>А. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Podvigina</surname><given-names>N. I.</given-names></name><name xml:lang="ru"><surname>Подвигина</surname><given-names>Н. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nekrasov</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Некрасов</surname><given-names>Д. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3850-7109</contrib-id><name-alternatives><name xml:lang="en"><surname>Nosov</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Носов</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758</italic></p></bio><bio xml:lang="ru"><p><italic>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</italic></p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-12-03" publication-format="electronic"><day>03</day><month>12</month><year>2022</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>81</fpage><lpage>92</lpage><history><date date-type="received" iso-8601-date="2022-03-27"><day>27</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-02-01"><day>01</day><month>02</month><year>2023</year></date></history><permissions><copyright-year>2022</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/1560">https://oncourology.abvpress.ru/oncur/article/view/1560</self-uri><abstract xml:lang="en"><p><bold>Background. </bold>Surgical treatment after chemotherapy is extremely difficult technically and should only be performed in a specialized medical center. The postoperative period after these surgical interventions is aimed not only at minimizing complications, but also at early mobilization and rehabilitation of patients. The principles of fast-track surgery, or ERAS (Enhanсed Recovery After Surgery) significantly reduce the incidence and degree of complications after various surgical interventions. However, the results of studies on the use of fast track in retroperitoneal lymphadenectomies have not yet been presented.</p><p><bold>Aim. </bold>To determine the effect of enhanced recovery program on treatment outcomes in patients with germ cell tumors of the testicle after retroperitoneal lymphadenectomy.</p><p><bold>Materials and methods. </bold>Retrospective analysis of 2 groups of patients (<italic>n </italic>= 93) treated at the N.N. Petrov National Medical Research Center of Oncology (Saint Petersburg) was performed. In the 1st group of patients, standard postoperative care after retroperitoneal lymphadenectomy was performed; in the 2nd group, fast track elements were used. Since the introduction of the ERAS protocol into clinical practice (September 2017), all patients have been included in the 2nd group.</p><p><bold>Results. </bold>The presence or absence of preoperative preparation did not affect the incidence of intraoperative complications (<italic>p</italic><italic> </italic>= 0.031). There were significant differences in the duration of hospitalization between the 1st and 2nd groups –15.3 and 11.9 days (<italic>p </italic>= 0.03), respectively. Assessment of the pain syndrome using the Numeric Rating Scale for Pain (NRS) showed that median pain level in the 1st group was significantly higher than in the 2nd group: 5 ± 1.5 and 3 ± 1.7, respectively (<italic>p </italic>= 0.04), which indicates a more severe and less controlled pain syndrome in the 1st group of patients. The rate of infectious complications in the postoperative wound in the 2nd group was 3 cases <italic>versus </italic>13 in the 1st group (<italic>p </italic>= 0.009). The rate of lymphorrhea in 2nd group was significantly lower (<italic>p </italic>= 0.003), median drainage duration was higher in 1st group (<italic>p </italic>&lt;0.05). In the 2nd group, 70.6 % of patients did not require drainage, which was an important factor in rapid rehabilitation.</p><p><bold>Conclusion. </bold>The use of fast-track principles in patients after retroperitoneal lymphadenectomy significantly reduces the incidence of postoperative complications and rehabilitation time.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение. </bold>Операция после химиотерапии технически крайне сложна и должна выполняться только в специализированном центре. Послеоперационный период после таких хирургических вмешательств направлен не только на нивелирование осложнений, но и на раннюю активизацию и реабилитацию пациентов. Принципы хирургии fast track (быстрый путь), или ERAS (ускоренное восстановление после операции), значимо снижают частоту и степень осложнений после многих хирургических вмешательств. Однако результатов исследований, посвященных применению fast traсk при забрюшинных лимфаденэктомиях, до сих пор не представлено.</p><p><bold>Цель</bold><bold> </bold><bold>исследования</bold><bold> </bold>– определение влияния принципов программы раннего восстановления (fast track) на результаты лечения пациентов после забрюшинной лимфаденэктомии при герминогенной опухоли яичка.</p><p><bold>Материалы</bold><bold> </bold><bold>и методы. </bold>Проведен ретроспективный анализ 2 групп больных (<italic>n</italic><italic> </italic>= 93), получивших лечение в НМИЦ онкологии им. Н.Н. Петрова (Санкт-Петербург). В 1-й группе после забрюшинной лимфаденэктомии выполняли стандартное послеоперационное ведение пациентов, во 2-й – с применением элементов fast track. С момента внедрения в клиническую практику протокола ERAS (сентябрь 2017 г.) всех пациентов включали во 2-ю группу.</p><p><bold>Результаты.</bold><bold> </bold>Наличие и отсутствие предоперационной подготовки не повлияли на частоту развития интраоперационных осложнений (<italic>p</italic><italic> </italic>= 0,031). Отмечены статистически значимые различия в длительности госпитализации между 1-й и 2-й группами – 15,3 и 11,9 сут (<italic>p</italic><italic> </italic>= 0,03). При оценке болевого синдрома по числовой рейтинговой шкале оценки боли (NRS) медиана уровня боли в 1-й группе была достоверно выше, чем во 2-й: 5 ± 1,5 и 3 ± 1,7 балла соответственно (<italic>p</italic><italic> </italic>= 0,04), что говорит о более выраженном и менее контролируемом болевом синдроме в 1-й группе пациентов. Частота развития инфекционных осложнений в послеоперационной ране во 2-й группе составила 3 случая против 13 случаев в 1-й группе (<italic>p</italic><italic> </italic>= 0,009). Частота формирования лимфореи во 2-й группе была достоверно ниже (<italic>p</italic><italic> </italic>= 0,003), медиана длительности дренирования была выше в 1-й группе (<italic>p</italic><italic> </italic>&lt;0,05). Во 2-й группе 70,6 % больных не нуждались в дренировании, что было важным фактором быстрой реабилитации.</p><p><bold>Заключение. </bold>Применение принципов fast track у пациентов после забрюшинной лимфаденэктомии значимо снижает частоту послеоперационных осложнений и сроки реабилитации.</p></trans-abstract><kwd-group xml:lang="en"><kwd>lymphadenectomy</kwd><kwd>germ cell tumor</kwd><kwd>testis</kwd><kwd>rehabilitation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лимфаденэктомия</kwd><kwd>герминогенные</kwd><kwd>опухоли</kwd><kwd>яичко</kwd><kwd>реабилитация</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was performed without external funding.</funding-statement><funding-statement xml:lang="ru">Исследование проведено без спонсорской поддержки.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Matveev V.B., Figurin K.M., Volkova M.I. et al. Retroperitoneal lymph node dissection after induction chemotherapy in metastatic testicular non-seminoma. Onkourologiya = Cancer Urology 2010;6(1):52–8. (In Russ.). DOI: 10.17650/1726-9776-2010-6-1-52-58</mixed-citation><mixed-citation xml:lang="ru">Матвеев В.Б., Волкова М.И., Фигурин К.М. и др. Забрюшинная лимфаденэктомия после индукционной химиотерапии при диссеминированных несеминомных герминогенных опухолях яичка. Онкоурология 2010;6(1):52–8. DOI: 10.17650/1726-9776-2010-6-1-52-58</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><mixed-citation>Beck S.D., Foster R.S., Bihrle R. et al. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 2007;110(6):1235–40. DOI: 10.1002/cncr.22898</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Busch J., Magheli A., Erber B. et al. Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis. BMC Urol;12:15. DOI: 10.1186/1471-2490-12-15</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Nosov A.K., Petrov S.B., Lushina P.A. et al. Fast track for partial nephrectomy. Onkourologiya = Cancer Urology 2019;15(3):47–55. (In Russ.). DOI: 10.17650/1726-9776-2019-15-3-47-55</mixed-citation><mixed-citation xml:lang="ru">Носов А.К., Петров С.Б., Лушина П.А. и др. Fast track при резекции почки. Онкоурология 2019;15(3):47–55. DOI: 10.17650/1726-9776-2019-15-3-47-55</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Luft V.M. Clinical Nutrition Guide. Saint Petersburg: Art-Express, 2016. Pp. 103–105. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Луфт В.М. Руководство по клиническому питанию. СПб.: АртЭкспресс, 2016. C. 103–105.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>Kehlet H., Wilmore D.W. Multimodal strategies to improve surgical outcome. Am J Surg 2002;183(6):630–41. DOI: 10.1016/s0002-9610(02)00866-8</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bardram L., Funch-Jensen P., Jensen P. et al. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet 1995;345(8952):763–4. DOI: 10.1016/s0140-6736(95)90643-6</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Zhuang C.L., Ye X.Z., Zhang X.D. et al. Enhanced recovery after surgery programs versus traditional care for colorectal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum 2013;56(5):667–78. DOI: 10.1097/DCR.0b013e3182812842</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>ERAS Compliance Group. The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg 2015;261(6):1153–9. DOI: 10.1097/SLA.0000000000001029</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Andersen J., Hjort-Jakobsen D., Christiansen P.S., Kehlet H. Readmission rates after a planned hospital stay of 2 versus 3 days in fast-track colonic surgery. Br J Surg 2007;94(7):890–3. DOI: 10.1002/bjs.5669</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Wille-Jørgensen P., Rasmussen M.S., Andersen B.R., Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database Syst Rev 2003;(4):CD001217. DOI: 10.1002/14651858.CD001217</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Song F., Glenny A.M. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 1998;85(9):1232–41. DOI: 10.1046/j.1365-2168.1998.00883.x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Carlisle J.B., Stevenson C.A. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2006;2006(3):CD004125. DOI: 10.1002/14651858.CD004125.pub2</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Tjandra J.J., Chan M.K.Y. Systematic review on the short-term outcome of laparoscopic resection for colon and rectosigmoid cancer. Colorectal Dis 2006;8(5):375–88. DOI: 10.1111/j.1463-1318.2006.00974.x</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Rigg J.R., Jamrozik K., Myles P.S. et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002;359(9314):1276–82. DOI: 10.1016/S0140-6736(02)08266-1</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Brandstrup B., Tonnesen H., Beier-Holgersen R. et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessorblinded multicenter trial. Ann Surg 2003;238(5):641–8. DOI: 10.1097/01.sla.0000094387.50865.23</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Azhar R.A., Bochner B., Catto J. et al. Enhanced recovery after urological surgery: a contemporary systematic review of outcomes, key elements, and research needs. Eur Urol 2016;70(1):176–87. DOI: 10.1016/j.eururo.2016.02.051</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Cerantola Y., Valerio M., Persson B. et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. Clin Nutr 2013;32(6):879–87. DOI: 10.1016/j.clnu.2013.09.014</mixed-citation></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Nosov A.K., Reva S.A., Berkut M.V., Petrov S.B. Early recovery program in the radical surgical treatment of patients with prostate cancer: experience of the specialized hospital. Onkourologiya = Cancer Urology 2016;12(4):60–9. (In Russ.). DOI: 10.17650/1726-9776-2016-12-4-60-69</mixed-citation><mixed-citation xml:lang="ru">Носов А.К., Рева С.А., Беркут М.В., Петров С.Б. Программа раннего восстановления при радикальном хирургическом лечении больных раком предстательной железы: опыт специализированного стационара. Онкоурология 2016;12(4):60–9. DOI: 10.17650/1726-9776-2016-12-4-60-69</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><mixed-citation>Arai Y., Kaiho Y., Yamada S. et al. Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes. Int Urol Nephrol 2012;44(5):1389–95. DOI: 10.1007/s11255-012-0195-z</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Nicolai N., Cattaneo F., Biasoni D. et al. Laparoscopic postchemotherapy retroperitoneal lymph-node dissection can be a standard option in defined nonseminomatous germ cell tumor patients. J Endourol 2016;30(10):1112–9. DOI: 10.1089/end.2016.0458</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Looijenga L.H., Gillis A.J., Stoop H. et al. Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl 2007;30(4):304–14; discussion 314–5. DOI: 10.1111/j.1365-2605.2007.00765.x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Jørgensen N., Rajpert-De Meyts E., Main K.M., Skakkebaek N.E. Testicular dysgenesis syndrome comprises some but not all cases of hypospadias and impaired spermatogenesis. Int J Androl 2010;33(2):298–303. DOI: 10.1111/j.1365-2605.2009.01050.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Heidenreich A., Pfister D., Witthuhn R. et al. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol 2009;55(1):217–24. DOI: 10.1016/j.eururo.2008.09.027</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Cary C., Masterson T.A., Bihrle R., Foster R.S. Contemporary trends in postchemotherapy retroperitoneal lymph node dissection: Additional procedures and perioperative complications. Urol Oncol 2015;33(9):389.e15–21. DOI: 10.1016/j.urolonc.2014.07.013</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Djaladat H., Nichols C., Daneshmand S. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol 2012;19(7):2388–93. DOI: 10.1245/s10434-012-2284-8</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Subramanian V.S., Nguyen C.T., Stephenson A.J., Klein E.A. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer. Urol Oncol 2010;28(5):504–9. DOI: 10.1016/j.urolonc.2008.10.026</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Nazzani S., Bandini M., Preisser F. et al. Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis. Surg Oncol 2019;28:201–7. DOI: 10.1016/j.suronc.2019.01.011</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Farro G., Gomez-Pinilla P.J., Di Giovangiulio M. et al. Smooth muscle and neural dysfunction contribute to different phases of murine postoperative ileus. Neurogastroenterol Motil 2016;28(6):934–47. DOI: 10.1111/nmo.12796</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Venara A., Neunlist M., Slim K. et al. Postoperative ileus: pathophysiology, incidence, and prevention. J Visc Surg 2016;153(6):439–46. DOI: 10.1016/j.jviscsurg.2016.08.010</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Evans J.G., Spiess P.E., Kamat A.M. et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M.D. Anderson experience. J Urol 2006;176(4 Pt 1):1463–7. DOI: 10.1016/j.juro.2006.06.016</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Saluja M., Gilling P. Venous thromboembolism prophylaxis in urology: A review. Int J Urol 2017;24(8):589–93. DOI: 10.1111/iju.13399</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Bustos Merlo A.B., Arcelus Martínez J.I., Turiño Luque J.D. et al. Form of presentation, natural history and course of postoperative venous thromboembolism in patients operated on for pelvic and abdominal cancer. Analysis of the RIETE registry. Cir Esp 2017;95(6):328–34. DOI: 10.1016/j.ciresp.2017.05.006</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Vedovati M.C., Becattini C., Rondelli F. et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 2014;259(4):665–9. DOI: 10.1097/SLA.0000000000000340</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Felder S., Rasmussen M.S., King R. et al. Prolonged thromboprophylaxis with low molecular weight heparin or abdominal or pelvic surgery. Cochrane Database Syst Rev 2019;3(3):CD004318. DOI: 10.1002/14651858.CD004318.pub4</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Dindo D., Clavien P.A. What is a surgical complication? World J Surg 2008;32(6):939–41. DOI: 10.1007/s00268-008-9584-y</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Alonso-Isa M., Medina-Polo J., Lara-Isla A. et al. Surgical wound infection in urology. Analysis of risk factors and associated microorganisms. Actas Urol Esp 2017;41(2):109–16. DOI: 10.1016/j.acuro.2016.07.003</mixed-citation></ref></ref-list></back></article>
